Molecular Evaluation of BCR/ABL1 in Chronic Myelogenous Leukemia (CML)

March 13, 2012
Expires March 13, 2014

Preview the program introduction

This Disease Management Strategies program is designed to give educational material regarding the use of BCR/ABL1 testing in the management of patients with chronic myelogenous leukemia (CML). With multiple tests for this target available at Mayo Clinic, each designed for a specific need, it can be confusing which to order and when. The talk will discuss each of the currently available tests and how they are best used together for clinical management of CML patients.

To view the full program:

• You must be a client of Mayo Medical Laboratories
• You must create (or sign in with) a user ID for MayoMedicalLaboratories.com

Go to the full program.